Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new publication citation is added to the Publications section, reporting Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in PD-L1-unselected, metastatic NSCLC. The publication record is updated to Revision: v3.5.4, replacing the prior v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T06:14:21.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s displayed revision version was incremented from **v3.5.2** to **v3.5.3**, reflecting a site/version update without altering the study details shown.
    Difference
    0.0%
    Check dated 2026-04-24T05:55:25.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The Spartalizumab publication citation was updated to Revision: v3.5.2 with an erratum added, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:31:58.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-26T11:26:45.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:08.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added site revision tag v3.4.2 and removed the prior funding/status notice (v3.4.1); these are maintenance updates to the site interface and do not affect trial content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T13:57:32.000Z thumbnail image

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.